AFAugusto Celso Scarparo Amato Filho

Augusto Celso Scarparo Amato Filho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Augusto Celso Scarparo Amato Filho has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of anti-amyloid therapies for Alzheimer’s disease in Brazil: a position paper from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology

    by Breno José Alencar Pires Barbosa, Elisa de Paula França Resende, Raphael Machado Castilhos, Wyllians Vendramini Borelli, Norberto Anízio Ferreira Frota, Marcio Luiz Figueredo Balthazar, Augusto Celso Scarparo Amato Filho, Jerusa Smid, Maira Tonidandel Barbosa, Artur Martins Coutinho, et al.

    Novel therapies for Alzheimer’s disease, particularly anti-amyloid drugs like lecanemab and donanemab, have shown modest clinical benefits but also significant risks. The present paper highlights the challenges of access to diagnosis, cost-effectiveness, safety, and the need for more representation of diverse populations in clinical trials. Recommendations include careful patient selection, risk-benefit analysis, and the importance of proven amyloid pathology for treatment. Future work involves further research on anti-amyloid therapies in Brazil and the development of more effective treatments for Alzheimer’s disease.


  • Open Access

    Cortical ribbon sign on neuroimaging in a patient with hepatic encephalopathy secondary to herbal medicine usage

    by Gabriel de Deus Vieira, Mariana Moreira Soares de Sá, Arthur de Medeiros Dias, Rafael Gemaque Lima Bentes, Augusto Celso Scarparo Amato, André Augusto Lemos Vidal de Negreiros, Ana Carolina Amaral de Andrade, Simone Reges Perales, Elaine Cristina de Ataide, Alexandre Foratto, et al.

    The use of herbal medicines is growing exponentially despite the lack of scientific evidence regarding their effectivity and toxicity. ( , ) Moreover, the use of herbal medicines have been reported to be common in patients with chronic liver disease (30–62%); these medicines can lead to hepatotoxicity and serious hepatic side effects. ( ) Hepatic encephalopathy is a complication of acute liver failure and chronic liver disease that causes cognitive dysfunction, motor deficits, and seizures. ( , ) Gastrointestinal hemorrhage,

  • Open Access

    Nonalcoholic Wernicke encephalopathy with petechial hemorrhage in the tectal region

    by Gabriel de Deus Vieira, Augusto Celso Scarparo Amato Filho, Alfredo Damasceno

    A 39-year-old woman, after an episode of acute appendicitis, developed necrosis and intestinal obstruction, requiring colectomy and ileostomy. After hospital discharge, she had a high output through the ileostomy and low food intake. A few months later, she developed bilateral nystagmus, ataxic syndrome and difficulty concentrating. Susceptibility weighted imaging (SWI) sequence of the brain magnetic resonance imaging (MRI) showed hypointensities in the mammillary bodies and inferior colliculi, which might represent microbleeds ([Figure 1]). Wernicke encephalopathy (WE) usually affects the mamillary bodies, thalami, and periaqueductal region. Rare hemorrhagic manifestations are reported in the literature, most in the mamillary bodies. The breakdown of the blood-brain barrier may contribute to this petechial hemorrhage in WE.[1] [2] All authors contributed equally to the present work. Received: 05 January 2023 Accepted: 25 February 2023 Article published online: 30 August 2023 © 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil